Fumiaki Ikeda

2.8k total citations
77 papers, 2.3k citations indexed

About

Fumiaki Ikeda is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Fumiaki Ikeda has authored 77 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 33 papers in Epidemiology and 29 papers in Pharmacology. Recurrent topics in Fumiaki Ikeda's work include Antifungal resistance and susceptibility (25 papers), Fungal Infections and Studies (14 papers) and Antibiotic Resistance in Bacteria (12 papers). Fumiaki Ikeda is often cited by papers focused on Antifungal resistance and susceptibility (25 papers), Fungal Infections and Studies (14 papers) and Antibiotic Resistance in Bacteria (12 papers). Fumiaki Ikeda collaborates with scholars based in Japan, United States and New Zealand. Fumiaki Ikeda's co-authors include Toru Nakai, Kazuo Hatano, Katsuyuki Maki, Shuichi Tawara, Satoru Matsumoto, Yoshimi Wakai, Toshio Goto, Yoshihiro Yokota, Yoshimi Matsumoto and Shōgo Kuwahara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Fumiaki Ikeda

75 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumiaki Ikeda Japan 26 1.1k 881 525 404 298 77 2.3k
Randall A. Prince United States 25 1.3k 1.2× 904 1.0× 703 1.3× 242 0.6× 184 0.6× 79 2.2k
Daniel J. Sheehan United States 17 1.6k 1.5× 1.0k 1.1× 302 0.6× 386 1.0× 157 0.5× 35 2.6k
Katsumasa Sato Japan 28 897 0.8× 1.1k 1.3× 285 0.5× 613 1.5× 153 0.5× 150 2.5k
Weiguo Liu United States 30 1.2k 1.1× 960 1.1× 1.3k 2.6× 509 1.3× 124 0.4× 65 3.4k
Gloria M. González Mexico 31 2.2k 2.0× 2.0k 2.2× 229 0.4× 368 0.9× 467 1.6× 163 3.1k
R. Williamson France 28 826 0.8× 397 0.5× 390 0.7× 650 1.6× 95 0.3× 60 3.1k
Ken Bartizal United States 27 1.9k 1.8× 1.3k 1.4× 535 1.0× 425 1.1× 180 0.6× 49 2.6k
N X Chin United States 28 633 0.6× 759 0.9× 1.4k 2.6× 412 1.0× 108 0.4× 62 2.3k
Mohsen Heidary Iran 25 746 0.7× 425 0.5× 142 0.3× 599 1.5× 124 0.4× 87 2.0k
Amy Flattery United States 22 1.8k 1.6× 1.2k 1.4× 495 0.9× 518 1.3× 247 0.8× 37 2.5k

Countries citing papers authored by Fumiaki Ikeda

Since Specialization
Citations

This map shows the geographic impact of Fumiaki Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiaki Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiaki Ikeda more than expected).

Fields of papers citing papers by Fumiaki Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumiaki Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiaki Ikeda. The network helps show where Fumiaki Ikeda may publish in the future.

Co-authorship network of co-authors of Fumiaki Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Fumiaki Ikeda. A scholar is included among the top collaborators of Fumiaki Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiaki Ikeda. Fumiaki Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yamaguchi, Hideyo, et al.. (2014). In vitro Antifungal Activity of Ravuconazole Against Isolates of Dermatophytes and Candida Species from Patients with Dermatomycoses. Medical Mycology Journal. 55(4). J157–J163. 6 indexed citations
3.
Koga, Yosuke, Shinichiro Irie, Masatoshi Tanaka, et al.. (2013). In vitro activities of antimicrobial combinations against clinical isolates of Neisseria gonorrhoeae. Journal of Infection and Chemotherapy. 19(6). 1218–1220. 21 indexed citations
4.
Kanayama, Akiko, Takeshi Saika, Fumiaki Ikeda, et al.. (2010). Rapidly spreading CTX-M-type β-lactamase-producing Proteus mirabilis in Japan. International Journal of Antimicrobial Agents. 36(4). 340–342. 15 indexed citations
5.
Suzuki, Kenji, Yuichi Kurono, Toshimitsu Kobayashi, et al.. (2009). [Antimicrobial susceptibility surveillance of recent isolates from otorhinolaryngological infections to garenoxacin and other antimicrobial drugs].. PubMed. 62(2). 71–8. 2 indexed citations
6.
Takeda, Shinobu, Fumiaki Ikeda, & Kazuo Hatano. (2008). In Vitro Antibacterial Activity of a New Cephalosporin, FR295389, against IMP-type Metallo-β-lactamase-producers. The Journal of Antibiotics. 61(1). 36–39.
7.
Takeda, Shinobu, Toru Nakai, Fumiaki Ikeda, & Kazuo Hatano. (2008). Overproduction of a Metallo-β-Lactamase by a Strong Promoter Causes High-Level Imipenem Resistance in a Clinical Isolate of <i>Pseudomonas aeruginosa</i>. Chemotherapy. 54(3). 181–187. 6 indexed citations
8.
Tomishima, Masaki, Hidenori Ohki, Akira Yamada, Katsuyuki Maki, & Fumiaki Ikeda. (2008). Novel echinocandin antifungals. Part 2: Optimization of the side chain of the natural product FR901379. Discovery of micafungin. Bioorganic & Medicinal Chemistry Letters. 18(9). 2886–2890. 30 indexed citations
9.
Tomishima, Masaki, Hidenori Ohki, Akira Yamada, Katsuyuki Maki, & Fumiaki Ikeda. (2008). Novel echinocandin antifungals. Part 1: Novel side-chain analogs of the natural product FR901379. Bioorganic & Medicinal Chemistry Letters. 18(4). 1474–1477. 18 indexed citations
10.
Takeda, Shinobu, Toru Nakai, Yoshimi Wakai, Fumiaki Ikeda, & Kazuo Hatano. (2006). In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 51(3). 826–830. 109 indexed citations
11.
Niimi, Kyoko, Katsuyuki Maki, Fumiaki Ikeda, et al.. (2006). Overexpression ofCandida albicans CDR1,CDR2, orMDR1Does Not Produce Significant Changes in Echinocandin Susceptibility. Antimicrobial Agents and Chemotherapy. 50(4). 1148–1155. 105 indexed citations
12.
Nakai, Toru, Kazuo Hatano, Fumiaki Ikeda, & Kazutoshi Shibuya. (2005). Electron microscopic findings for micafungin-treated experimental pulmonary aspergillosis in mice. Medical Mycology. 43(5). 439–445. 8 indexed citations
13.
Ikeda, Fumiaki, et al.. (2003). MIC of micafungin against fresh clinical isolates of genus Candida and Aspergillus. 51(8). 485–489. 1 indexed citations
14.
Sugimoto, Masahiro, Ichirō Uchida, Takashi Mashimo, et al.. (2003). Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins. Neuropharmacology. 45(3). 304–314. 149 indexed citations
15.
Barrett, David A., et al.. (2001). Synthesis and biological activity of novel macrocyclic antifungals. Bioorganic & Medicinal Chemistry Letters. 11(14). 1843–1849. 7 indexed citations
16.
Barrett, David A., et al.. (2001). Synthesis and biological activity of novel macrocyclic antifungals. Bioorganic & Medicinal Chemistry Letters. 11(4). 479–482. 16 indexed citations
17.
Hirasawa, Ryuto, et al.. (1998). Low Prevalence of Helicobacter pylori Infection in Patients with Hamartomatous Fundic Polyps. Digestive Diseases and Sciences. 43(4). 766–772. 28 indexed citations
18.
Ikeda, Fumiaki, Yoshihiro Yokota, & Y Mine. (1991). Formation of Biofilm by Slime Producing Staphylococcus epidermidis and Bactericidal Activity of Cefazolin. Kansenshogaku zasshi. 65(7). 875–882. 1 indexed citations
19.
Furukawa, Yoshiko, Shoei Furukawa, Fumiaki Ikeda, E Satoyoshi, & Kyozo Hayashi. (1986). Aliphatic side chain of catecholamine potentiates the stimulatory effect of the catechol part on the synthesis of nerve growth factor. FEBS Letters. 208(2). 258–262. 38 indexed citations
20.
Ikeda, Fumiaki, et al.. (1983). Antagonism of cephem antibiotics and β-Lactamase induction in gram-negative bacilli. Chemotherapy. 31(3). 304–308. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Randall A. Prince Breakdown of academic impact, for papers by Daniel J. Sheehan Breakdown of academic impact, for papers by Katsumasa Sato Breakdown of academic impact, for papers by Weiguo Liu Breakdown of academic impact, for papers by Gloria M. González Breakdown of academic impact, for papers by R. Williamson Breakdown of academic impact, for papers by Ken Bartizal Breakdown of academic impact, for papers by N X Chin Breakdown of academic impact, for papers by Mohsen Heidary Breakdown of academic impact, for papers by Amy Flattery
Rankless by CCL
2026